Liabilities and stockholders' equity components shown as percentage of total liabilities and stockholders' equity.
The cash flow statement provides information about Bristol-Myers Squibb Co.'s cash receipts and cash payments during an accounting period, showing how these cash flaws link the ending cash balance to the beginning balance shown on Bristol-Myers Squibb Co.'s statement of financial position.
Measures the income of Bristol-Myers Squibb Co. relative to its revenuess and invested capital.
CAPM is a theory concentrated with deriving the expected rates of return on risky assets based on the assets' systematic risk levels. Systematic risk is the variability of returns that is due to macroeconomic factors that affect all risky assets. It cannot be eliminated by diversification.
To calculate EBITDA analysts start with net earnings. To that earnings number, interest, taxes, depreciation, and amortization are added. EBITDA as a pre-interest number is a flow to all providers of capital.
The income statement (statement of earnings) reports on the performance of Bristol-Myers Squibb Co., the result of its operating activities.